Whole-exome sequencing powered by insights from the genome
Whole-exome sequencing (WES) is a powerful tool for analyzing the approximately 22,000 genes in the human genome and understanding the different types of mutations that cause diseases. In this video, Madhuri Hegde, Ph.D., FACMG, formerly of Emory University, discusses her experience creating an augmented exome that maximizes the utility of WES through thoughtful curation of the panel content.
Discover more and sequence less by leveraging a comprehensive exome design that provides enhanced variant detection and increased discovery power. Ignite your exome sequencing for more impact on your clinical research.
SureSelect Clinical Research Exome V4 will provide you with superior utility by design, deeper coverage of clinically relevant content, and confident variant detection.
The SureSelect Clinical Research Exome V4 datasheet highlights the key performance metrics of the exome panel including target coverage and coverage uniformity.
Learn about the streamlined whole-exome enrichment workflow combined with variant analysis and interpretation for rare and inherited diseases.
In this webinar entitled, “Implementing an Augmented Whole-Exome Panel Powered by Genome-Derived Insights for Clinical Research,” our speakers uncover some of the advantages of exome sequencing, such as how:
“Switching to the Agilent SureSelect CRE V4 Enrichment Kit has been a game-changer for our NGS service. Having previously utilized the CRE V2 kit, our journey with Agilent's enrichment kits has been a long and fruitful one. However, the upgrade to CRE V4 has truly exceeded our expectations, delivering exceptional results and garnering immense satisfaction from our valued customers.”
Stephanie Kujawa
Product Manager
Eurofins Genomics
Share your information below to be contacted by an Agilent representative. Find out how you can ignite your inherited disease discovery.
For Research Use Only. Not for use in diagnostic procedures.
